Remedium Lifecare [REMLIFE] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Remedium Lifecare

BSE
Loading...

Innova Captab

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Remedium Lifecare wins in 5 metrics, Innova Captab wins in 13 metrics, with 0 ties. Innova Captab appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricRemedium LifecareInnova CaptabBetter
P/E Ratio (TTM)25.1737.87Remedium Lifecare
Price-to-Book Ratio1.415.12Remedium Lifecare
Debt-to-Equity Ratio2,600.5135.24Innova Captab
PEG Ratio0.327.22Remedium Lifecare
EV/EBITDA3,209.7327.17Innova Captab
Profit Margin (TTM)1.17%9.98%Innova Captab
Operating Margin (TTM)1.65%11.68%Innova Captab
EBITDA Margin (TTM)1.65%11.68%Innova Captab
Return on Equity4.85%13.37%Innova Captab
Return on Assets (TTM)0.12%8.12%Innova Captab
Free Cash Flow (TTM)$-11.44B$-1.09BInnova Captab
1-Year Return-83.46%7.89%Innova Captab
Price-to-Sales Ratio (TTM)0.303.78Remedium Lifecare
Enterprise Value$12.80B$51.82BInnova Captab
EV/Revenue Ratio2.903.98Remedium Lifecare
Gross Profit Margin (TTM)4.88%37.21%Innova Captab
Revenue per Share (TTM)$8$227Innova Captab
Earnings per Share (Diluted)$0.06$22.65Innova Captab
Beta (Stock Volatility)1.20N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Remedium Lifecare vs Innova Captab Stock Performance Analysis

Loading Price Chart...

Remedium Lifecare
Innova Captab
Remedium Lifecare Stock Overview | Innova Captab Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Remedium Lifecare0.00%-1.32%14.50%57.89%-29.58%-70.41%
Innova Captab-0.73%-0.29%-5.29%0.45%8.94%-22.70%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Remedium Lifecare-83.46%-98.90%-96.94%-96.94%-96.94%-96.94%
Innova Captab7.89%58.40%58.40%58.40%58.40%58.40%

News Based Sentiment: Remedium Lifecare vs Innova Captab

Remedium Lifecare

News based Sentiment: POSITIVE

Remedium Lifecare experienced a significant month with a major contract win in the UK and approval for a substantial rights issue. These developments, coupled with positive Q1 FY26 results, suggest a potential turning point for the company and a strengthening investment case, despite some insider selling activity.

View Remedium Lifecare News Sentiment Analysis

Innova Captab

News based Sentiment: MIXED

September brought a mix of positive developments – a new facility, strong quarterly results – alongside regulatory challenges with the NPPA fixing drug prices. While the company shows strong growth potential, these pricing controls introduce uncertainty and warrant a 'mixed' sentiment, making it a significant month for investors to assess the company's future trajectory.

View Innova Captab News Sentiment Analysis

Performance & Financial Health Analysis: Remedium Lifecare vs Innova Captab

MetricREMLIFEINNOVACAP
Market Information
Market Cap i₹1.33B₹49.37B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i13,810,70848,888
90 Day Avg. Volume i8,468,75945,067
Last Close₹1.50₹857.60
52 Week Range₹0.80 - ₹9.34₹662.00 - ₹1,260.00
% from 52W High-83.94%-31.94%
All-Time High₹4,547.80 (Jul 03, 2023)₹1,260.00 (Jan 06, 2025)
% from All-Time High-99.97%-31.94%
Growth Metrics
Quarterly Revenue Growth0.46%0.20%
Quarterly Earnings Growth1.84%0.05%
Financial Health
Profit Margin (TTM) i0.01%0.10%
Operating Margin (TTM) i0.02%0.12%
Return on Equity (TTM) i0.05%0.13%
Debt to Equity (MRQ) i2,600.5135.24
Cash & Liquidity
Book Value per Share (MRQ)₹1.07₹167.66
Cash per Share (MRQ)₹0.02₹11.41
Operating Cash Flow (TTM) i₹-16,381,918,000₹282.88M
Levered Free Cash Flow (TTM) i₹21.29M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Remedium Lifecare vs Innova Captab

MetricREMLIFEINNOVACAP
Price Ratios
P/E Ratio (TTM) i25.1737.87
Forward P/E iN/A20.69
PEG Ratio i0.327.22
Price to Sales (TTM) i0.303.78
Price to Book (MRQ) i1.415.12
Market Capitalization
Market Capitalization i₹1.33B₹49.37B
Enterprise Value i₹12.80B₹51.82B
Enterprise Value Metrics
Enterprise to Revenue i2.903.98
Enterprise to EBITDA i3,209.7327.17
Risk & Other Metrics
Beta i1.20N/A
Book Value per Share (MRQ) i₹1.07₹167.66

Financial Statements Comparison: Remedium Lifecare vs Innova Captab

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)REMLIFEINNOVACAP
Revenue/Sales i₹1.13B₹3.52B
Cost of Goods Sold i₹1.08B₹2.21B
Gross Profit i₹55.35M₹1.31B
Research & Development iN/AN/A
Operating Income (EBIT) i₹18.71M₹410.54M
EBITDA i₹18.71M₹565.82M
Pre-Tax Income i₹57.12M₹426.77M
Income Tax i₹10.64M₹116.62M
Net Income (Profit) i₹46.49M₹310.15M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)REMLIFEINNOVACAP
Cash & Equivalents i₹2.82M₹155.19M
Total Current Assets i₹17.20B₹7.03B
Total Current Liabilities i₹16.76B₹3.53B
Long-Term Debt i₹0₹2.45B
Total Shareholders Equity i₹438.91M₹9.59B
Retained Earnings iN/A₹4.53B
Property, Plant & Equipment i₹83,000₹442.93M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)REMLIFEINNOVACAP
Operating Cash Flow iN/A₹378.60M
Capital Expenditures iN/A₹-1.21B
Free Cash Flow iN/A₹-908.56M
Debt Repayment iN/A₹-7.69M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricREMLIFEINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i13,810,70848,888
Average Daily Volume (90 Day) i8,468,75945,067
Shares Outstanding i577.65M57.22M
Float Shares i301.99M15.70M
% Held by Insiders i0.23%0.72%
% Held by Institutions i0.00%0.19%

Dividend Analysis & Yield Comparison: Remedium Lifecare vs Innova Captab

MetricREMLIFEINNOVACAP
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A